SCMP Amitiza is proven drug for constipation and it has more indication approval and primery drug for health care. The liquid version of Amitiza for children and seniors who cannot swallow pills will be available in late 2014, early 2015. SCMP balance sheet is superior with low float and at least 3 drugs in phase 3 and a few in phase 2 and 1.
There have been two confirmed reports of overdosage with Amitiza. The first report involved a 3-year-old child who accidentally ingested 7 or 8 capsules of 24 mcg of Amitiza and fully recovered. The second report was a study patient who self-administered a total of 96 mcg of Amitiza per day for 8 days. The patient experienced no adverse reactions during this time.
If the same thing happens with IRWD, LINZESS drug, for sure the 3 years old kid and the adult patient could not survive.